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ABSTRACT
Background Causative gene mutations have been
identiﬁed in about 2% of those with amyotrophic lateral
sclerosis (ALS), often, but not always, when there is
a strong family history. There is an assumption that there
is a genetic component to all ALS, but genome-wide
association studies have yet to produce a robustly
replicated result. A deﬁnitive estimate of ALS heritability
is therefore required to determine whether ongoing
efforts to ﬁnd susceptibility genes are worth while.
Methods The authors performed two twin studies, one
population- and one clinic-based. The authors used
structural equation modelling to perform a meta-analysis
of data from these studies and an existing twin study to
estimate ALS heritability, and identiﬁed 171 twin pairs in
which at least one twin had ALS.
Results and discussion Five monozygotic twin pairs
were concordant-affected, and 44 discordant-affected.
No dizygotic twin pairs were concordant-affected, and
122 discordant-affected. The heritability of sporadic ALS
was estimated as 0.61 (0.38 to 0.78) with the unshared
environmental component 0.39 (0.22 to 0.62). ALS has
a high heritability, and efforts to ﬁnd causative genes
should continue.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a neurode-
generative disease of motor neurons with a median
survival of about 2 years. The lifetime prevalence is
about 1 in 400,
1 but the appalling prognosis means
the point prevalence is only 5 per 100000 persons.
2
In 95% of cases, there is no family history of ALS,
but a study has found that the risk to siblings or
offspring of a proband is elevated between nine and
17 times.
3 There is thus a familial tendency to ALS,
which is best regarded as a complex disease.
There have been many genetic studies of ALS,
4
but the only consistent ﬁndings have been the
identiﬁcation of six genes in which mutation
predisposes to ALS, both in families and in sporadic
cases, accounting for about 2% of ALS overall; these
are SOD1, TARDBP, FUS, VAPB, ANG and
OPTN.
5e12 Genome-wide association studies have
not resulted in independent replication of ﬁndings,
although replication of a large study in a second
large internal cohort has been successful.
13 There is,
nevertheless, the assumption of a genetic compo-
nent to all ALS. Atwin study would help determine
whether this assumption is reasonable by allowing
an estimate of ALS heritability. The British Motor
Neuron Disease (MND) Twin Study
14 made a start
on this process by reporting the likely range in
which the ALS heritability value would lie: 0.38 to
0.85. We have therefore collected twin data from
two further sources: the Swedish Twin Registry
15
and the King’s College Hospital Motor Neuron
Disease Clinic Register.
16 We have analysed these
two new data sets with the existing data used for
the British MND Twin Study, independently but
simultaneously in a meta-analysis framework, to
generate for the ﬁrst time an estimate of ALS
heritability.
METHODS
Data collection
Data for the British MND Twin Study were
extracted from the published manuscript.
14
Methods for the Swedish Twin Registry and King’s
Register have been previously described.
31 6For the
King’s Register, pedigree records as obtained at the
initial visit of each participant were used to identify
twins. Zygosity status was self-reported, a method
shown in the Swedish Twin Registry to be correct
in 99% of twin pairs.
15 Concordance was deﬁned as
reportedinthepedigreeatthetimeoflastfollow-up.
The two new studies were approved by the
Research Ethics Committees of each institution.
Informed written consent to participate in
research was obtained for all participants.
Familiality
Although the distinction between familial and
sporadic ALS is to a large extent artiﬁcial, the
population under study consists of two groups:
those with a strong family history of ALS in whom
we can assume a strong genetic component, and
those without, in which the demonstration of
a heritable component would be most useful. We
therefore tested the effect of including and
excluding individuals with a family history of ALS
in a ﬁrst-degree relative. For the British MND Twin
Study, this information was provided in the
published information. For the Swedish Twin
Registry, data were linked to the Swedish Multi-
Generational Register, which has family history
information for those born after 1932 who were
still alive in or after 1967, the Swedish Inpatient
Register (1973 to 2004) and the Swedish Causes of
Death Register (1961 to 2003) to identify relatives
with ALS. For the King’s Register, pedigree struc-
ture and family history taken both at the initial
visit and at subsequent follow-up were used to
identify families with affected ﬁrst degree relatives.
Statistical methods
Genetic model-ﬁtting is based on biometrical
genetic theory where contributions of additive
genetic (A), dominant genetic (D), shared environ-
mental (C) and unshared environmental (E) effects
on the trait are estimated by examining how often
twins of different types correlate. Monozygotic
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Research paper(MZ) twins share all their genes, while dizygotic (DZ) twins
share only half on average. A trait that is strongly genetic would
therefore be expected to be strongly correlated between MZ
twins, but show about half as strong a correlation between DZ
twins. Calculation of correlations between twins for a contin-
uous trait, such as height, is straightforward, but when the trait
under study is discrete, as is ALS, a statistical measure called
tetrachoric correlation is used, which assumes an underlying
normal distribution of liability with a threshold effect deter-
mining if someone is affected or not. A DZ correlation which is
less than half that of the MZ suggests the effect of dominance,
whereas a DZ correlation which is higher than half that of the
MZ suggests the effect of shared environment.
17 As these two
sources of variance are confounded, ACE and ADE models are
ﬁtted separately. Model ﬁt is indicated by c
2 statistics and
related p values.
We performed a meta-analysis to maximise power. Twins of
unknown zygosity were excluded from analysis. Tetrachoric
correlations for ALS for MZ and DZ twins were calculated from
contingency tables summarising the number of concordant-
affected, concordant-unaffected and discordant pairs, using the
Mx program.
18 The calculations assume that the joint liability
distribution is bivariate normal, and a threshold determines
affection or normality. Data for the British MND Twin Study
and the King’s Register were derived from local case register
information on ALS, rather than being direct population-based
observations, as is the case for the Swedish Twin Registry. The
number of concordant-unaffected pairs is therefore unknown,
requiring ascertainment correction and the liability threshold to
be ﬁxed to the prevalence of ALS. Population studies put the
median age of onset of ALS at about 70 years of age,
19 so the
prevalence of ALS was taken as about 1 in 740 (z-value thres-
hold¼3.00), which is the approximate lifetime risk to this age.
1
No such corrections were necessary for the Swedish data. The
combined data were then used to estimate the overall MZ and
DZ twin correlations. Because there were no concordant-
affected DZ twin pairs in any study, we also modelled the effect
of the next DZ twin pair sampled being concordant-affected.
20
Different sex twin pairs were included in the analysis, even
though there is a differential risk for males and females with
ALS, to avoid a loss of power and to allow comparison with the
British MND Twin Study, which did not differentiate between
twins by sex.
RESULTS
Numbers studied
The British MND Twin Study examined 10872 death certiﬁcates
of people with MND, identifying 75 twin pairs for further study.
It excluded seven twin-pairs where one of the pair had died
before the proband developed disease, and also excluded one pair
on the basis they were from a family with known familial ALS.
It is arguable whether these are valid reasons for exclusion, and
so we did not exclude such pairs. Of 26 MZ probands identiﬁed,
four were double twin pairs and therefore counted twice. Thus,
the original study analysed 20 discordant and one concordant
MZ pair, and 44 discordant and no concordant DZ pairs. We
analysed 22 discordant and two concordant-affected MZ pairs,
and 51 discordant and no concordant-affected DZ pairs overall,
and excluded one MZ concordant pair for analysis of sporadic
ALS.
The Swedish Twin Registry study examined 86441 twin pairs,
of which 14824 were MZ, 43070 were DZ and 28547 were of
unknown zygosity. Of the MZ pairs, 15 were discordant and
two concordant for ALS. Of the DZ pairs, 58 were discordant
and none concordant for ALS. For six twins, no family history
data were available. For the remainder, no family history of ALS
was identiﬁed in ﬁrst-degree non-twin relatives.
The King’s Register contained records of 1502 individuals
with ALS and 3480 ﬁrst-degree relatives. There were 21 twin
pairs in which at least one twin had ALS. There were eight MZ
pairs, one concordant and seven discordant for ALS, and 13
DZ pairs, all discordant. The concordant MZ pair and one of the
DZ pairs had a family history of ALS in a ﬁrst degree relative and
were excluded from the analysis of sporadic ALS.
Model results
Results for all ﬁtted genetic models are presented in table 1.
The model estimate of prevalence for ALS in the Swedish data
(threshold z-value¼3.21) was close to the ﬁxed threshold chosen
for the British MND Twin Study and King’s Register based on
life-time prevalence by age 70. The MZ and DZ twin correla-
tions were 0.73 (0.55 to 0.85) and 0.16 ( 0.24 to 0.47), respec-
tively for the twins including familial cases and 0.65 (0.42 to
0.81) and 0.16 ( 0.51 to 0.47) for sporadic cases only, indicating
dominance genetic effects in both cases. For sporadic ALS,
although an ADE model ﬁtted the data well (c
2
(2)¼3.16,
p¼0.21), the heritability of ALS could not be meaningfully
decomposed into additive and dominance genetic effects, most
likely because of the lack of concordant-affected DZ twins. To
resolve this, we explored two alternative procedures. First, we
interpreted an AE model. This ﬁtted the data well (c
2
(3)¼4.60,
p¼0.20) with heritability estimated at 0.61 (0.38 to 0.78).
Second, we adopted an approach used by the British MND Twin
Study and others: all studies were assumed to have a single
concordant-affected DZ twin pair as the next studied. In this
situation, the MZ and DZ twin correlations were 0.65 (0.42 to
0.81) and 0.47 (0.27 to 0.63) respectively, indicating shared
environmental effects. Although the ACE model ﬁtted the data
well (c
2
(2)¼3.65, p¼0.16), the 95% CI for the shared environ-
mental component included zero. The reduced AE model
Table 1 Genetic model-ﬁtting results: variance components (with 95% CI)
Genetic model Twins included
Modelled as next
dizygotic pair concordant Additive genetic component (A)
Common environmental
(C) or dominant genetic
(D) component
Unique environmental
component (E)
ADE All No 0.00 (0.00 to 0.80) 0.73 (0.00 to 0.85) 0.27 (0.15 to 0.45)
AE All No 0.71 (0.53 to 0.84) e 0.29 (0.16 to 0.47)
ACE All Yes 0.52 (0.04 to 0.85) 0.21 (0.00 to 0.58) 0.27 (0.15 to 0.45)
AE All Yes 0.76 (0.60 to 0.86) e 0.24 (0.14 to 0.40)
ADE Sporadic No 0.00 (0.00 to 0.75) 0.64 (0.00 to 0.81) 0.36 (0.19 to 0.59)
AE Sporadic No 0.61 (0.38 to 0.78) e 0.39 (0.22 to 0.62)
ACE Sporadic Yes 0.36 (0.00 to 0.80) 0.30 (0.00 to 0.63) 0.35 (0.19 to 0.57)
AE Sporadic Yes 0.70 (0.52 to 0.83) e 0.30 (0.17 to 0.48)
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Research paper(dropping C) showed an additive genetic component of 0.70
(0.52 to 0.83).
DISCUSSION
We estimate the heritability of sporadic ALS to be 0.61 (0.38 to
0.78). The strength of this study lies in the extra power available
from combining the two new studies and the previous British
study in a meta-analysis. This has allowed us to independently
but simultaneously model the different studies, despite their
different designs. The value we obtain and the conﬁdence
interval lie within the range predicted by the British MND Twin
Study. Although it can be difﬁcult to estimate heritability in
relatively rare diseases, our study combines data from 10872
MND death certiﬁcates over a 10-year period, a country-wide
study of 86441 twin pairs and a clinic-based study of 4982
individuals with ALS or their family members, generating results
from 171 ALS twin pairs.
Our analysis differs from the British MND Twin study in an
important aspect. We used structural equation modelling.
21 This is
a powerful likelihood-based technique that allows an estimate of
heritability despite the lack of concordant-affected DZ twin pairs,
without resorting to statistical workarounds. The British MND
Twin study used an accepted method in which the next affected
DZ twin observed is assumed to come from a concordant pair.
20
When we adopted this approach, the results were not very
different from our unmodiﬁed analysis (table 1). This is important,
as it suggests that a moderate increase in sample size designed to
identify more twin pairs will not greatly change our results.
When familial samples were included in our analysis, the
heritability estimate was, as expected, higher, but the overall
ﬁndings are not greatly different from those for sporadic ALS,
whether or not we allowed for the next DZ twins identiﬁed to
be concordant-affected.
We have previously estimated the heritability of age of onset
of SOD1-mediated ALS as 0.29 (0 to 0.42) using a variance
components approach in ALS pedigrees.
22 This contrasts with
the much higher estimate for susceptibility heritability we
obtain here, indicating independent genetic effects on age of
onset and susceptibility.
Comorbidity of ALS and frontotemporal dementia, and
pathological overlap is well recognised. No formal twin study
has been performed for frontotemporal dementia, but in more
than 41% of cases, there is some family history, suggesting
a high heritability. We did not distinguish between individuals
with and without frontotemporal dementia concurrent with
ALS, and our heritability estimate will therefore also have
implications for frontotemporal dementia.
This study has important implications for sporadic ALS.
Clinically, the knowledge of a signiﬁcant genetic component
means that the question of why ALS has developed can be more
conﬁdently explained in terms of complex disease genetics. For
research, despite the difﬁculties with replication of genome-wide
association studies,
4 we can pursue more highly powered
genome-wide association studies boldly, explore statistical
methods for interactions and epistasis, and use techniques to
ﬁnd rare genetic variants, copy number variants, microsatellites
and epigenetic changes.
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